Growth Metrics

Erasca (ERAS) R&D In Process (2020 - 2022)

Erasca posted quarterly R&D In Process of $98.0 million for Q4 2022, up 4800.0% on a QoQ basis from $2.0 million in Q1 2022.

Erasca (ERAS) has 3 years of R&D In Process data on file, last reported at $98.0 million in Q4 2022.

  • For the quarter ending Q4 2022, R&D In Process changed N/A year-over-year to $98.0 million; the trailing twelve-month figure through Jun 2023 stood at $98.0 million (up 2563.04% YoY), and the FY2022 full-year result was $100.0 million, up 821.83% from the prior year.
  • R&D In Process for Q4 2022 stood at $98.0 million, up from $2.0 million in the prior quarter.
  • Across five years, R&D In Process topped out at $98.0 million in Q4 2022 and bottomed at $75000.0 in Q3 2020.
  • The 3-year median for R&D In Process is $3.7 million (2021), against an average of $20.5 million.
  • The widest annual swing landed in 2021, when R&D In Process surged 2140.0%; it then plunged 45.65% in 2022.
  • A 3-year view of R&D In Process shows it stood at $32.3 million in 2020, then tumbled by 94.79% to $1.7 million in 2021, then soared by 5733.33% to $98.0 million in 2022.
  • The last three R&D In Process figures came in at $98.0 million (Q4 2022), $2.0 million (Q1 2022), and $1.7 million (Q3 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D In Process (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 500,000.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 101.90 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Erasca 4.21 Bn 3.97 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 98.00 Mn
Mar 31, 2022 2.00 Mn
Sep 30, 2021 1.68 Mn
Jun 30, 2021 5.49 Mn
Mar 31, 2021 3.68 Mn
Dec 31, 2020 32.26 Mn
Sep 30, 2020 75,000.00